BIRMINGHAM, Ala. ( WBRC) - Alabama Attorney General Steve Marshall has announced that the state settled a lawsuit with a ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

Baptist Memorial Hospital–Attala is expanding access to cancer care and other outpatient treatments through its Infusion ...

If you have any interest in increasing your muscle mass, energy level, mental clarity, bone density, skin elasticity, deep ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Drugs currently shortage FDA total 75 as of Dec. 30, down from 194 in June, mainly hospital injectables and acute care meds.

Donald Trump has sparked a fresh round of health concerns after trying to conceal his hand bruising while meeting with Ukraine's President Volodymyr Zelensky, RadarOnline. com can reveal.